3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
3
Breast Neoplasms
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Stomach Neoplasms
1
Solid Tumors With High Expression of Nectin4
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Precancerous Conditions
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Mouth Neoplasms
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
139
Cisplatin
76
Cetuximab
53
Carboplatin
50
Paclitaxel
40
Nivolumab
40
Radiotherapy
38
Docetaxel
34
Radiotherapy, Intensity-Modulated
30
Magnetic Resonance Spectroscopy
25
Fluorouracil
21
Specimen Handling
20
Platinum
14
1,2-diaminocyclohexaneplatinum II citrate
13
Taxes
12
cemiplimab
11
Radiation
11
Ipilimumab
11
Drug Therapy
11
atezolizumab
10
Surgical Procedures, Operative
10
tislelizumab
9
Biopsy
9
durvalumab
8
Radiosurgery
8
Chemoradiotherapy
8
Albumin-Bound Paclitaxel
8
Standard of Care
7
130-nm albumin-bound paclitaxel
7
Immune Checkpoint Inhibitors
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Immunohistochemistry
×
1 year
×
Clear all
No trials found.